Riskpilot← Back to searchSign inGet full accessFREKHAUG FYSIOTERAPISENTER AS
ASActiveOrg 987635991Havnevegen 28, 5918 FrekhaugPhysiotherapy activities · NACE 8695Est. 20052 employees
Revenue 2025
NOK 856K
+13% vs 2024
EBITDA margin
52.3%
+29% vs 2024
Equity ratio
95.6%
Financial strength
Net profit 2025
NOK 376K
+34% vs 2024
| Revenue | NOK 856K | +13% |
| EBITDA | NOK 448K | +29% |
| Net profit | NOK 376K | +34% |
| Total assets | NOK 4,2M | +11% |
| Equity | NOK 4M | +10% |
| Employees | 2 | — |
Legal name
FREKHAUG FYSIOTERAPISENTER AS
Org number
987635991
Legal form
Aksjeselskap
NACE code
8695 · Physiotherapy activities
Founded
4. januar 2005
Share capital
NOK 55 102
Employees
2 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Fysioterapivirksomhet - helsefremmende og forebyggende arbeid, herunder rådgivning og kursvirksomhet, -og hertil naturlig tilknyttede virksomheter. Kjøp og utleie av fast eiendom.
Address
Havnevegen 28, 5918 Frekhaug
Email
oekalle@online.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 729 | 716 | 720 | 755 | 856 |
| Staff expenses | −106 | −107 | −110 | −114 | −118 |
| EBITDA | 387 | 159 | 344 | 348 | 448 |
| Depreciation & amort. | −65 | −65 | −68 | −68 | −63 |
| EBIT | 321 | 94 | 276 | 281 | 385 |
| Net financials | 2 | 3 | 18 | 79 | 97 |
| Profit before tax | 324 | 97 | 294 | 359 | 483 |
| Tax | 71 | 21 | 65 | 79 | 106 |
| Net profit | 253 | 76 | 229 | 280 | 376 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 3 209 | 3 234 | 3 508 | 3 801 | 4 203 |
| Equity | 3 056 | 3 131 | 3 361 | 3 641 | 4 017 |
| Long-term debt | 66 | 67 | 65 | 63 | 60 |
| Short-term debt | 88 | 36 | 82 | 97 | 126 |
| Total debt | 154 | 103 | 147 | 160 | 186 |
EBITDA margin
52.3%
This company
15.8%
Market median
+231% vs market
20212025
Equity ratio
95.6%
This company
38.2%
Market median
+150% vs market
20212025
Return on equity
9.4%
This company
18.4%
Market median
-49% vs market
20212025
Net profit margin
43.9%
This company
8.1%
Market median
+442% vs market
20212025
Asset turnover
0.20×
This company
1.12×
Market median
-82% vs market
20212025
Debt / equity
0.05×
This company
0.62×
Market median
+92% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
MÅ Deputy Member | Deputy Member | 2020 |
AK Deputy Member | Deputy Member | 2020 |
SB Deputy Member | Deputy Member | 2020 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2020 | |
| Board of Directors | 2020 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 22.22% | 22.22% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of FREKHAUG FYSIOTERAPISENTER AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Målfrid Åmellem Kallekleiv | Deputy Member | 0 companies |
| Ann Kristin Legernes | Deputy Member | 0 companies |
| Stian Brynildsen Olsen | Deputy Member | 0 companies |
| Øystein Kallekleiv | Chairman | 0 companies |
| Linn Erstad | Board of Directors | 0 companies |